$3.17
2.92% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US7599101026
Symbol
KRMD

Repro-Med Systems, Inc. Stock price

$3.17
+0.57 21.92% 1M
+0.92 40.89% 6M
+0.72 29.12% YTD
+1.00 46.08% 1Y
-0.37 10.45% 3Y
-1.13 26.28% 5Y
+2.78 712.82% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
+0.09 2.92%
ISIN
US7599101026
Symbol
KRMD
Sector

Key metrics

Market capitalization $141.23m
Enterprise Value $134.74m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 4.37
P/S ratio (TTM) P/S ratio 4.58
P/B ratio (TTM) P/B ratio 7.55
Revenue growth (TTM) Revenue growth 11.57%
Revenue (TTM) Revenue $31.99m
EBIT (operating result TTM) EBIT $-7.05m
Free Cash Flow (TTM) Free Cash Flow $-1.70m
Cash position $8.81m
EPS (TTM) EPS $-0.26
P/E forward negative
P/S forward 4.31
EV/Sales forward 4.11
Short interest 2.06%
Show more

Is Repro-Med Systems, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Repro-Med Systems, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Repro-Med Systems, Inc. forecast:

5x Buy
100%

Analyst Opinions

5 Analysts have issued a Repro-Med Systems, Inc. forecast:

Buy
100%

Financial data from Repro-Med Systems, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
32 32
12% 12%
100%
- Direct Costs 13 13
2% 2%
40%
19 19
23% 23%
60%
- Selling and Administrative Expenses 20 20
3% 3%
62%
- Research and Development Expense 5.43 5.43
11% 11%
17%
-6.15 -6.15
37% 37%
-19%
- Depreciation and Amortization 0.91 0.91
10% 10%
3%
EBIT (Operating Income) EBIT -7.05 -7.05
33% 33%
-22%
Net Profit -12 -12
45% 45%
-37%

In millions USD.

Don't miss a Thing! We will send you all news about Repro-Med Systems, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Repro-Med Systems, Inc. Stock News

Neutral
Seeking Alpha
2 days ago
KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript
Neutral
Business Wire
2 days ago
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the third quarter ended September 30, 2024, and raised full year 2024 reve...
Neutral
Business Wire
9 days ago
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will be participating in two upcoming Investor Conferences. KORU Medical's manag...
More Repro-Med Systems, Inc. News

Company Profile

Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Chester, NY.

Head office United States
CEO Linda Tharby
Employees 82
Founded 1980
Website www.korumedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today